Back

Cardiometabolic parameters by the degree of maintenance of weight reduction in tirzepatide-treated adults with obesity: post hoc study of SURMOUNT MAINTAIN Trial

30 August 2026 (08:45 - 09:00)
Organised by: Logo
Congress Presentation Part of: Prevention in 2026: artificial intelligence, obesity and personalised cardiovascular care Obesity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Luke Joseph Laffin

Cleveland Clinic, Cleveland (United States of America)

5 More presentations in this session

Presentation thumbnail
The Personal Plaque Threshold: A Causal AI Biological World Model for Selecting Individualized LDL Targets to Personalize Cardiovascular Prevention
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Risk of Ischemic Stroke With Beta-Blockers: Evidence From Randomized Clinical Trials
Professor F. Messerli (Luzern, CH)
Slides
Presentation thumbnail
High-Intensity Interval Training Reduces 10-Year Mortality in Older Adults: The Generation 100 Randomized Controlled Trial
Mr S. Midttun (Trondheim, NO)
Slides Video
Presentation thumbnail
Machine learning and hemodynamic profile-based clinical decision support systems for personalized guideline-concordant antihypertensive treatment in primary care (LIGHT-precision)
Professor X. Zheng (Beijing, CN)
Slides Video
Presentation thumbnail
BetaBlocker discontinuation in patients with chronic coronary syndrome, prior myocardial infarction: a pooled analysis of the ABYSS and SMART-DECISION randomised trials.
Professor J. Silvain (Paris, FR)
Slides Video

Access the full session

Session thumbnail
Prevention in 2026: artificial intelligence, obesity and personalised cardiovascular care
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 08:45 CET
You may be interested in
thumbnail
Congress Presentation
Weight loss is the easy part, the struggle is maintenance
28 August 2026
thumbnail
Congress Presentation
Impact of oral semaglutide on cardiovascular risk factors in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: a SOUL post hoc analysis
30 August 2025
thumbnail
Congress Presentation
Incretins and heart failure with preserved ejection fraction: the evidence
11 May 2026
thumbnail
Congress Presentation
BMI shift and associated cardiometabolic risk factors in people with type 2 diabetes and obesity and/or overweight: a post hoc analysis from SURMOUNT-2
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources